Drug Approval Package
Apidra (Insulin Glulisine [rDNA
Origin]) Injection
Company: Aventis Pharmaceutical, Inc.
Application No.: 021629
Approval Date: 04/16/2004
-
Approval Letter(s) (PDF)
-
Printed Labeling (PDF)
-
Chemistry Review(s) (PDF)
-
Pharmacology Review(s)
Part 1 (PDF)
Part 2 (PDF)
Part 3 (PDF) -
Statistical Review(s) (PDF)
-
Microbiology Review(s) (PDF)
-
Administrative Document(s) & Correspondence
Part 1 (PDF)
Part 2 (PDF)
Part 3 (PDF)
Part 4 (PDF)
Date created: June 282004
Note: Documents in PDF format require the Adobe Acrobat Reader®.